v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from operating activities    
Net loss $ (18,824) $ (17,470)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,381 2,701
Loss on asset disposal 21
Depreciation and amortization 1,063 426
Shares issued for services 51 19
Other 1
Changes in assets and liabilities:    
Prepaid expenses and other assets (100) (94)
Lease right-of-use assets 370 342
Accounts payable and accrued expenses (288) 458
Lease liabilities (374) (355)
Net cash used in operating activities (15,720) (13,952)
Cash flows from investing activities    
Purchases of property and equipment (2,493) (1,700)
Net cash used in investing activities (2,493) (1,700)
Cash flows from financing activities    
Proceeds from at-the-market sales of common stock, net 2,114 278
Proceeds from exercise of common stock warrants 1,251 742
Proceeds from public offering of common stock and warrants, net 7,344 20,065
Proceeds from private placements of common stock and warrants, net 11,367
Net cash provided by financing activities 22,076 21,085
Net increase in cash and cash equivalents 3,863 5,433
Cash and cash equivalents, at beginning of year 9,232 3,799
Cash and cash equivalents, at end of year 13,095 9,232
Noncash investing and financing activities:    
Receivable from transfer agent for warrant exercise proceeds 142
Cash paid for:    
Income taxes $ 2 $ 2